Key result
Nondrug therapies are recommended over early drugs for low-risk mild hypertension with diastolic below 100.
Why the study?
Does early and aggressive drug therapy improve outcomes in patients with mild hypertension (diastolic BP < 100 mm Hg) compared to non-drug therapies?
Does early and aggressive drug therapy improve outcomes in patients with mild hypertension (diastolic BP < 100 mm Hg) compared to non-drug therapies?
For patients with mild hypertension (DBP < 100 mm Hg) and low cardiovascular risk, non-pharmacological therapies should be prioritized for 6-12 months before considering drug therapy.
No takes yet. Share an insight, caveat, or question.
Supports initial nondrug approach in low-risk mild hypertension; leaves open need for RCTs to confirm outcomes.
N. M. Kaplan (1983) conducted a review in Mild hypertension. Antihypertensive drug therapy vs. Nondrug therapies was evaluated. Nondrug therapies for 6 to 12 months are recommended over early drug therapy for low-risk patients with mild hypertension and diastolic blood pressure below 100 mm Hg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: